Variable | Glavonoidâ„¢ Pre (n = 12) | Glavonoidâ„¢ Post (n = 12) | Placebo Pre (n = 11) | Placebo Post (n = 11) |
---|---|---|---|---|
Cholesterol (mg·dL-1)** | 147.9 ± 6.4 | 159.8 ± 8.0 | 148.4 ± 7.0 | 178.7 ± 11.6 |
Triglycerides (mg·dL-1) | 76.6 ± 10.4 | 81.3 ± 10.6 | 76.4 ± 10.7 | 95.8 ± 8.9 |
HDL-C (mg·dL-1) | 48.0 ± 2.2 | 47.8 ± 2.4 | 47.9 ± 2.1 | 50.0 ± 2.7 |
VLDL-C (mg·dL-1) | 15.4 ± 2.1 | 16.3 ± 2.2 | 15.3 ± 2.2 | 19.3 ± 1.8 |
LDL-C (mg·dL-1)** | 84.5 ± 6.2 | 95.7 ± 8.1 | 85.2 ± 5.7 | 109.5 ± 10.0 |
LDL-C/HDL-C | 1.8 ± 0.2 | 2.1 ± 0.2 | 1.8 ± 0.2 | 2.2 ± 0.2 |
Total:HDL-C | 3.1 ± 0.2 | 3.5 ± 0.3 | 3.2 ± 0.2 | 3.6 ± 0.2 |
Free Fatty Acids (mmol·L-1) | 0.41 ± 0.1 | 0.30 ± 0.0 | 0.30 ± 0.0 | 0.32 ± 0.1 |
Malondialdehyde (μmol·L-1) | 0.88 ± 0.09 | 0.84 ± 0.08 | 0.87 ± 0.11 | 0.84 ± 0.09 |